摘要
肺巨噬细胞通过特异性和非特异性机制,在先天免疫和免疫反应中发挥作用,即吞噬作用,并且能通过主要组织相容性复合体、T细胞活化与炎性因子的释放而对抗原加工与提呈产生重要影响。尽管他们在正常状态下对损伤有保护作用,但它们能引起多种肺疾病,因为它们可以通过聚集其他炎症细胞形成肺泡空间、释放炎症细胞因子或刺激胶原沉积的来介导疾病过程。肺巨噬细胞是治疗肺病的极佳靶点。随着纳米技术的发展,针对这些细胞的靶向药物的载体已经被科学家所设计。常用的方法之一是使对肺巨噬细胞表面受体具有亲和力的配体附着在纳米载体上。本综重点讲述了肺巨噬细胞在宿主防御中的重要性、其对不同肺疾病的影响,以及肺泡巨噬细胞的靶向性的不同措施。
关键词: 巨噬细胞,给药系统,配体,巨噬细胞受体,甘露糖受体,靶向。
图形摘要
Current Drug Targets
Title:Targeted Drug Delivery Systems for Lung Macrophages
Volume: 16 Issue: 14
Author(s): Ana Costa, Bruno Sarmento and Vítor Seabra
Affiliation:
关键词: 巨噬细胞,给药系统,配体,巨噬细胞受体,甘露糖受体,靶向。
摘要: Lung macrophages present an effective role in innate and immune response through specific and non-specific mechanisms, namely phagocytosis, antigen processing and presentation through major histocompatibility complex, activation of T cells and inflammatory cytokines release. Despite their protective role against injury in normal condition, they can cause several lung conditions, since they can mediate several processes, through recruitment of other inflammatory cells for alveolar space, release of proinflammatory cytokines or stimulation of collagen deposition. Lung macrophages constitute a good therapeutic target. With the development of nanotechnology, new carriers have been designed to target drugs towards these cells. One of the commonly used approaches is the attachment of ligands with affinity to receptors presented at lung macrophage surface, to the nanocarriers. This review will focus on the importance of lung macrophages in host-defense, their influence on different pulmonary diseases and different strategies for alveolar macrophage targeting.
Export Options
About this article
Cite this article as:
Ana Costa, Bruno Sarmento and Vítor Seabra , Targeted Drug Delivery Systems for Lung Macrophages, Current Drug Targets 2015; 16 (14) . https://dx.doi.org/10.2174/1389450115666141114152713
DOI https://dx.doi.org/10.2174/1389450115666141114152713 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Approaches Targeting KV10.1 Open a Novel Window for Cancer Diagnosis and Therapy
Current Medicinal Chemistry Active Targeting Strategies for Anticancer Drug Nanocarriers
Current Drug Delivery Bioactive Albumin-Based Carriers for Tumour Chemotherapy
Current Cancer Drug Targets Editorial (Mini Thematic Issue: Immunotherapy – A Pivotal Mechanism in the Fight of Cancer)
Reviews on Recent Clinical Trials Plant Polyphenols and Oral Health: Old Phytochemicals for New Fields
Current Medicinal Chemistry Nuclear Factor Kappa B: A Potential Target to Persecute Head and Neck Cancer
Current Drug Targets Meet Our Editorial Board Member
Anti-Cancer Agents in Medicinal Chemistry Targeting the Hippo Pathway for Anti-cancer Therapies
Current Medicinal Chemistry The Salivary miRNome: A Promising Biomarker of Disease
MicroRNA Tumor Specific Imaging Using Tc-99m and Ga-68 Labeled Radiopharmaceuticals
Current Medical Imaging Bioinformatics Approaches for Anti-cancer Drug Discovery
Current Drug Targets Antitumor Activity of Copper (I)–Nicotinate Complex and Autophagy Modulation in HCC1806 Breast Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Looking at Drug Resistance Mechanisms for Microtubule Interacting Drugs: Does TUBB3 Work?
Current Cancer Drug Targets Oral Cavity-Associated Immune System: What is New?
Current Immunology Reviews (Discontinued) The Proteolytic Activation of Angiogenic and Lymphangiogenic Growth Factors in Cancer – Its Potential Relevance for Therapeutics and Diagnostics
Current Medicinal Chemistry Detection of Lysyl Oxidase-Like 2 (LOXL2), a Biomarker of Metastasis from Breast Cancers Using Human Blood Samples
Recent Patents on Biomarkers Recent Advances in Molecular Image-Guided Cancer Radionuclide Therapy
Current Drug Targets Tumor Stroma Manipulation By MSC
Current Drug Targets Endoglin (CD105): A Target for Anti-angiogenetic Cancer Therapy
Current Drug Targets The Role of YY1 in Oncogenesis and Its Potential as a Drug Target in Cancer Therapies
Current Cancer Drug Targets